A recent study found that supplementation with French pine bark extract helped manage symptoms of fibromyalgia.
Photo © iStockphoto.com/J-Elgaard
A recent study1 found that supplementation with French pine bark extract (Pycnogenol from Horphag Research; Hoboken, NJ) helped manage symptoms of fibromyalgia. In the study, 50 female patients with idiopathic fibromyalgia were assigned to receive Pycnogenol with standard management or standard management alone for four weeks. None of the subjects were taking any drugs, and all of the subjects have elevated levels of oxidative stress at inclusion.
Results showed that the percentage of patients taking NSAIDS as rescue medication was significantly higher in the standard management group compared to the group taking Pycnogenol. The same was true for the use of corticosteroids. Subjects taking Pycnogenol also demonstrated a significant reduction in symptoms and complaints compared to standard management alone.
More specifically, subjects taking Pycnogenol saw improvements in the following symptoms:
Reference
Nutritional Outlook's Women in Nutraceuticals Roundtable: The Future of Women's Health Research
July 19th 2024Watch "The Future of Women's Health Research," a roundtable discussion presented by Nutritional Outlook in partnership with Women in Nutraceuticals. This roundtable is supplement to a recent article commissioned by WIN and published by Nutritional Outlook, titled “Taking Initiative: Can the WHI’s model help the nutraceutical industry answer questions the study didn’t even ask?”
Recent animal study finds that Lysoveta may help reduce neonatal brain injury
July 17th 2024A recent animal study found that lysophosphatidylcholine (LPC)-bound omega-3 long-chain polyunsaturated fatty acids (LCPUFAs), marketed as Lysoveta by Aker BioMarine, protected against neonatal hypoxic-ischemic (HI) brain injury in mice.